Celestica Now Certified to ISO 13485 for Medical Device Manufacturing in Romania
TORONTO, May 2, 2013 /PRNewswire/ - Celestica Inc. (NYSE, TSX: CLS), a global leader in the delivery of end-to-end product lifecycle solutions, is pleased to announce that its Oradea, Romania facility is now certified to ISO 13485.
ISO 13485 is an internationally recognized quality management system (QMS) standard for the medical industry. It requires strict adherence to quality and reliability standards in healthcare, including corrective actions to drive consistency for medical devices.
"This is an important milestone for Celestica as we extend our medical device manufacturing and engineering services in Europe, strengthening Celestica's global supply chain network," said Kevin Walsh, Vice President, Celestica HealthTech. "This certification is a further demonstration of Celestica's ongoing commitment to make investments to achieve market-leading quality and regulatory compliance for our global healthcare customers."
The Oradea, Romania facility is one of Celestica's ISO 13485-certified Centers of Excellence for medical manufacturing, joining Portland, OR, United States; San Jose, CA, United States; Galway, Ireland; Valencia, Spain; Suzhou, China; Johor Bahru, Malaysia; and Serangoon, Singapore.
In addition to ISO 13485 certification, Celestica is also fully qualified to meet other rigorous standards of the medical industry around the globe, such as ISO 9001, ISO 14001, Class 7 Clean Rooms, FDA-registered sites, robust cGMP and QS processes, and QSR/cGMP-compliant facilities.
Celestica is dedicated to delivering end-to-end product lifecycle solutions to drive our customers' success. Through our simplified global operations network and information technology platform, we are solid partners who deliver informed, flexible solutions that enable our customers to succeed in the markets they serve. Committed to providing a truly differentiated customer experience, our agile and adaptive employees share a proud history of demonstrated expertise and creativity that enhances our customers' ability to overcome complex challenges.
For further information on Celestica, visit its website at www.celestica.com.
About Celestica HealthTech
Celestica HealthTech works with medical device companies to help them bring innovative technologies to market faster and more efficiently. We collaborate with our customers to improve patient care through innovative thinking and advanced technical expertise. Our manufacturing, supply chain and after-market solutions accelerate product development and rapid delivery of quality healthcare technology.
For further information on Celestica HealthTech, visit its website at www.celesticahealthtech.com.
Celestica Safe Harbour and Fair Disclosure Statement
Statements contained in this news release that are not historical facts
are forward-looking statements. Such forward-looking statements
include, without limitation, statements regarding management's plans to
expand device manufacturing and engineering services in Europe; the
anticipated impact of such expansion on the company's supply chain
network; potential investments in the healthcare business segment; and
the intended benefits of such investments for our healthcare customers.
Such forward-looking statements are predictive in nature and are based
on current expectations, forecasts or assumptions involving risks and
uncertainties that could cause actual outcomes to differ materially
from the forward-looking statements themselves. For those statements,
we claim the protection of the safe harbor for forward-looking
statements contained in the U.S. Private Securities Litigation Reform
Act of 1995, and in applicable Canadian provincial and territorial
securities legislation. Forward-looking statements are not guarantees
of future actions, events or outcomes. Persons reading this news
release are cautioned that factors that could cause actual events or
results to differ materially from those suggested in these
forward-looking statements include, but are not limited to, regulatory,
design, engineering, intellectual property, technological and
competitor risk and the other industry-specific and company-specific
risks, uncertainties and factors identified in our various public
filings at www.sedar.com and www.sec.gov including our Annual Report on Form 20-F and subsequent reports on Form
6-K filed with the U.S. Securities and Exchange Commission and our
Annual Information Form filed with the Canadian Securities
Administrators. Forward-looking statements are provided for the purpose
of providing information about management's current expectations and
plans relating to the future. Readers are cautioned that such
information may not be appropriate for other purposes. Except as
required by applicable law, we disclaim any intention or obligation to
update or revise any forward-looking statements, whether as a result of
new information, future events or otherwise.
SOURCE Celestica Inc.